Robust Performance Across Platform Led by Midstream
CALGARY, AB, Aug. 1, 2025 /CNW/ - AltaGas Ltd. ("AltaGas" or the "Company") (TSX: ALA) reported second quarter...
WASHINGTON, July 31, 2025 /PRNewswire/ -- The American Pharmacists Association (APhA) is deeply concerned with the Advisory Committee on Immunization Practices (ACIP) Secretariat's decision to...
CALGARY, AB, July 31, 2025 /CNW/ - Stampede Drilling Inc. ("Stampede" or the "Corporation") (TSXV: SDI) announces today its consolidated financial and operational results...
Landmark 30th Anniversary EnerCom Denver – The Energy Investment Conference Announces Energy Transition and Emerging Technology Session Schedule
Qualified Investors and Analysts Can Register at...
Total revenue in the quarter of $304.9 million grew 15% year-over-year and exceeded outlook
Gross margin improved to 42%, with gross profit increasing 19% year-over-year exceeding...
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, July 31, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with cancer, infectious diseases and autoimmune diseases, today announced that it will report second quarter financial results, before the US markets open on Thursday, August 7, 2025.
MONTREAL, July 30, 2025 /CNW/ - In light of the widespread suffering, loss of human life, and growing international calls for an immediate and lasting...
CALGARY, AB, July 30, 2025 /CNW/ - Kiwetinohk Energy Corp. ("Kiwetinohk" or, the "Company") (TSX: KEC) today reported its second quarter 2025 results and...
GREELEY, Colo., July 30, 2025 (GLOBE NEWSWIRE) -- Pilgrim’s Pride Corporation (NASDAQ: PPC), one of the world's leading food companies, reports its second quarter 2025 financial results.